BPC-157 is one of the most talked-about peptides in sports medicine and recovery. It is widely promoted online for healing tendons, muscles and the gut, yet few people realize how thin the human evidence actually is. This article explains what BPC-157 is, how it appears to work, what the research shows so far, and what to consider before using it.
What is BPC-157?
BPC-157 (“body protection compound 157”) is a synthetic chain of 15 amino acids. It is based on a fragment of a protein found naturally in human gastric juice. Unlike many peptides, it is stable in stomach acid, which is why it has been studied both as an injection and in oral form.
How does BPC-157 work?
Most of what we know about its mechanism comes from cell and animal studies. In that research, BPC-157 appears to:
- Promote new blood vessel formation (angiogenesis), partly through VEGF signaling, which may improve blood supply to injured tissue
- Support tendon and ligament repair, with increased fibroblast activity and better collagen organization in animal models
- Influence nitric oxide pathways, which affect blood flow and the lining of blood vessels
- Protect the gut lining in models of ulcers and intestinal injury
These effects are biologically plausible. However, results seen in rats and cell cultures often don’t carry over to people.
What does the research show in humans?
This is where caution is needed. A 2025 systematic review of BPC-157 in orthopedic and sports medicine identified 36 studies. Thirty-five were preclinical (animal or laboratory studies), and only one was in humans.1 That human study was a retrospective review of 12 patients with chronic knee pain who received BPC-157 injections into the knee. Seven reported improvement lasting more than six months.2 There was no control group.
In short, BPC-157 has promising animal data and a small amount of low-quality human data. There are no large, controlled human trials showing that it speeds healing, and no long-term human safety data.
Is BPC-157 safe?
Animal studies have not shown toxicity at the doses tested, and side effects reported by people are usually mild, such as redness or irritation at the injection site. But the 2025 review found no formal clinical safety data in humans.1 Points to be aware of:
- Product quality. Much of the BPC-157 sold online is labeled “for research use only” and may be under-dosed or contaminated. Any use should involve a regulated, traceable source and medical supervision.
- Cancer. Because BPC-157 promotes new blood vessel growth, there is a theoretical concern for anyone with active or previous cancer, and it is best avoided in that situation.
- Unknowns. Long-term effects, and effects in pregnancy, are not known.
Legal and sport status
BPC-157 is not approved as a medicine in any country. In 2023, the US FDA placed it in Category 2 for compounding pharmacies, meaning there was insufficient evidence of safety in humans. It is also specifically banned by the World Anti-Doping Agency (WADA) at all times, so athletes in tested sports should not use it.1
Injection vs. oral BPC-157
- Subcutaneous injection (under the skin, often near the injured area) is the form used in most musculoskeletal studies and is generally preferred for tendon, ligament and muscle injuries.
- Oral capsules are sometimes used for gut-related goals because the peptide is stable in stomach acid.
Human evidence for either route is limited.
The bottom line
BPC-157 is an interesting peptide with encouraging animal research, but human evidence is still very limited and its long-term safety is unknown. It should never replace proper diagnosis, physiotherapy or surgical care when an injury needs it. If you are considering BPC-157, discuss it with a doctor who can review your medical history and explain what is and isn’t known.
Related reading
- Thymosin alpha-1: an immune-regulating peptide
- Tesamorelin: the peptide that boosts your own growth hormone
- What drives muscle growth?
References
- Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025;21(4):485–495. doi:10.1177/15563316251355551
- Lee E, Padgett B. Intra-articular injection of BPC 157 for multiple types of knee pain. Altern Ther Health Med. 2021.
